Loading transcript...
Click for full transcript
Chapters & Sections (288)
▼
00:01
Host Introduction and Guest Invitation
00:33
Travel to Ukraine and Training Overview
01:05
Legal Restrictions on Psychedelic Research in Ukraine
01:35
Draft Legislation and Government Efforts
02:06
Field Experience in Lviv and Air Raid Sirens
02:36
Cemetery Visit and Emotional Impact
03:09
Discussion of Trauma in Conservative Societies
03:41
Personal Representation and Philanthropic Goals
04:12
Upcoming Speaking Engagements in Beirut
04:43
Frustration with Legal Progress and Anecdotal Evidence
05:17
Early Use of MDMA in Therapy Circles
05:48
Transition to Party Drug and the Stark Club Story
06:21
Larry Hagman’s Connection to Psychedelic Culture
07:23
Personal Interaction with Larry Hagman and Genie Bong Anecdote
08:24
Psychedelic Culture in the 1960s
08:55
Positive Drug Story from a Beloved Star
09:26
MAPS Origins During the Reagan Era
09:56
Frustration and Persistence in Early MAPS Work
10:29
Administrative Law Judge Decision on Scheduling
11:02
Appeals Court Challenges to DEA Decisions
11:32
DEA Reassessment and Legal Strategy
12:03
Public Domain Status of MDMA and MAPS Mission
12:33
Illegal Emergency Scheduling by the DEA
13:05
Future of Psychedelic Research and Conferences
13:37
Frustration Over Prohibitionist Laws
14:09
Comparing Prescription Drug Availability to Psychedelics
14:40
Historical Misconceptions About Crack Babies
15:12
Stigma and Criminalization of Pregnant Drug Users
15:45
Counterproductive Effects of the Drug War on Public Health
16:14
Needle Park and Safe Injection Site Experience
16:46
Overwhelming Capacity and Open‑Air Drug Market
17:17
Portland’s Transformation from Hippie Hub to Overcrowded City
17:47
Local Solutions Attracting Wider Populations
18:49
Humanizing Approach to Substance Abuse
19:21
Rick Perry’s Support for Psychedelic Initiatives
20:11
Political Divide on Psychedelics
20:54
Therapeutic Clinics vs. Ketamine Without Therapy
21:25
Importance of Integration and Preparation in Psychedelic Treatment
22:27
Neuroplasticity and Critical Periods from Psychedelics
24:01
Researcher Collaboration with Military Veterans
24:32
Potential for Non-Psychedelic Psychedelics in Neurological Disorders
25:04
Public Perception and Safety Concerns
25:35
Cluster Headache Intervention with Psychedelic Substances
26:06
Institutional Resistance and Ethical Hurdles
26:37
Strategic Use of Non-Cychedelic LSD Derivatives
27:09
Clinical Trial Design and Outcome Expectations
27:39
Results of Bromodex Study and Comparative Efficacy
28:11
Funding Challenges for Non-Psychedelic Therapies
28:42
Political Advocacy and Military Support
29:14
Bridging Perspectives Between Advocates and Skeptics
30:17
Personal Reflection on Discipline Versus Consciousness Expansion
30:48
Concluding Thoughts on Work Ethic and Psychedelic Use
31:50
Carl Sean as a Hidden Stoner Scientist
32:22
Mentorship and Medical Research on Marijuana
32:54
Personal Reflections on Drug Law Reform
33:25
Texas Attorney General and Austin Decriminalization Conflict
33:56
Game Warden Investigation of Illegal Grow Operations
34:27
Cartel-Controlled Marijuana Production in National Forests
34:58
Illicit Market Economics and Illegal Pesticide Use
35:31
Legalization vs. Criminalization Debate on Tax Revenue
36:01
Attorney General’s Argument for Decriminalization
36:33
Comparing Alcohol and Marijuana Regulation
37:04
Historical Impact of Prohibition on Organized Crime
37:35
Social Acceptance and Personal Choice Regarding Substances
38:05
Psychedelics for End-of-Life Anxiety
38:38
Public Figures and Psychedelic Advocacy
39:08
Taxation of Marijuana in Different States
39:40
Economic Benefits vs. Youth Risks
40:11
Peyote Ceremonies in Indigenous Communities
40:42
Age and Dosage Considerations in Ritual Use
41:13
Ceremonial Settings Reduce Developmental Harm
41:43
Rituals and the Formation of Adult Identity
42:14
Bar Mitzvah as a Failed Rite of Passage
43:47
LSD Experience as Personal Rite of Passage
44:20
Comparing European and American Youth Substance Use
45:19
Prohibition Effects on Drug Potency
46:56
Hyperthermia and Overhydration from MDMA Use
47:28
Rhabdomyolysis from Excessive Exercise
48:29
Statistical Comparison of Rabdo and Water Overconsumption
49:00
Horseback Riding vs. Ecstasy in Risk Rankings
49:31
Cheerleading and Other Physical Activities as High-Risk Sports
50:33
Legalization of Dangerous Recreational Activities
51:36
Propaganda and the Misrepresentation of Drug Risks
52:06
Need for Evidence-Based Policy on Psychedelics
53:08
Psychedelic Therapy for PTSD and Sexual Abuse Survivors
54:12
Veterans Administration Collaboration with MAPS
54:45
VA Stigma and Initial Funding for MDMA Studies
55:16
$10 Million Defense Grant for MDMA Research
55:46
Veterans Administration PTSD Study Overview
56:18
Retraumatization in Traditional Exposure Therapies
56:49
MDMA with Prolonged Exposure Trial in Texas
57:20
MDMA Combined with Acceptance and Commitment Therapy at Walter Reed
57:53
Cognitive Behavioral Conjoint Therapy Development
58:25
Early FDA Approval and Historical Use of MDMA
58:58
Serotonin Depletion Concerns and 5HTP Discussion
59:29
Two-Day MDMA Therapy Protocol
1:00:33
Post-MDMA Rest and Integrative Sessions
1:01:04
Family-Centered MDMA Therapy for Cancer Patients
1:01:34
Expanding MDMA Therapy to Veterans and Partners
1:02:04
Challenges of Scaling PTSD Treatment in the U.S.
1:03:07
Early Group Therapy Pilot at Portland VA
1:03:40
Separating Military Sexual Trauma Groups
1:04:10
Adding a Third MDMA Session in Group Format
1:04:42
Climate-Related PTSD Study in Australia
1:05:13
Israel Post‑October 7th Trauma Group Trial
1:05:43
Individual vs. Group Therapy Randomized Comparison
1:06:47
Hybrid Individual/Group Integration Model at Sunstone
1:07:19
FDA Approval Timeline for Group Therapy
1:07:50
Challenges of Double‑Blind Psychedelic Trials
1:08:20
Low vs. Full Dose MDMA in Therapy
1:08:51
Dose‑Response Studies from Phase 2 Trials
1:09:21
Unexpected Findings in Low Dose MDMA Efficacy
1:10:57
Veteran, Firefighter, and Police Officer Dose Comparison
1:11:28
Evaluating Depression and PTSD Symptoms in Randomized Groups
1:12:01
Therapeutic Dose Determination and Unexpected Outcomes
1:12:33
FDA Phase 2 Meeting and Transition to Phase Three
1:13:04
Special Protocol Assessment Negotiations with FDA
1:13:36
Random Assignment and Independent Rating Procedures
1:14:06
Telemedicine Assessment Using CAPS Scale
1:15:07
FDA Advisory Committee Concerns About Functional Unblinding
1:15:40
Discussion of Double-Blind Limitations in Psychedelic Studies
1:16:42
Negotiation Outcomes and Potential Phase 4 Pathway
1:17:45
Phase Three Study Results – Severe PTSD
1:18:05
Responder Rates and Clinical Significance in Severe PTSD Study
1:18:47
Phase Three Study Results – Moderate to Severe PTSD
1:19:19
Control Group Outcomes and Therapist Effort in Moderate Study
1:19:50
Therapeutic Structure and Dropout Rates
1:20:22
Supportive Therapy Model for Psychedelic Sessions
1:21:23
Fidelity and Safety Outcomes in MDMA Trials
1:22:30
Advocacy and Legislative Efforts
1:23:33
Early Interest in Psychedelics and Vietnam Draft Resistance
1:24:37
Guidance Counselor Support and Influential Literature
1:26:41
Dream Narrative of Survival and Purpose
1:27:43
Jesus Theme in Psychedelic Experience
1:28:13
Interconnectedness and Dehumanization Prevention
1:28:45
LSD Storage and Youth Connection
1:29:17
Motivation from Psychedelic Experiences
1:29:50
Family Refugee Background and American Dream
1:30:20
Privileged Jewish Identity and Responsibility
1:31:23
Privilege as a Catalyst for Social Change
1:32:27
Maslow and Economic Survival Constraints
1:32:58
Mission to Reintroduce Psychedelic Healing
1:34:01
FDA Response and Research Momentum
1:34:33
Interconnectedness as a Barrier to War
1:35:06
Historical Psychedelic Influence on Culture
1:36:40
Nixon Administration's Drug Strategy
1:37:13
Elocidian Mysteries and Psychedelic Potions
1:37:43
Church Suppression of Psychedelics
1:38:15
Witch Hunts and Indigenous Shaman Suppression
1:38:46
Prehistoric Tribal Dynamics
1:39:16
The Glass Bead Game and Post-War Idealism
1:39:48
Abstraction of the Glass Bead Game and Elite Control
1:40:18
TED Talks on Psychedelics and Global Tension
1:41:20
Current Geopolitical Conflicts and Psychedelic Healing
1:41:50
Combatants for Peace Initiative
1:42:22
Visa Challenges for Palestinian Speakers
1:42:53
Neuroscience of Shared Psychedelic Experiences
1:43:25
Genetic and Tribal Roots of Conflict
1:43:59
Fundamentalism vs. Mysticism in Religious Contexts
1:44:29
Human DNA Similarity and Interconnectedness
1:44:59
DNA and Human Commonalities
1:45:29
Suspension of Illusionary Mysteries and Power Dynamics
1:46:02
Propaganda, Lies, and the Misuse of Psychedelic Tools
1:46:32
Religion, Power, and the Contextualization of Psychedelics
1:47:03
Therapeutic Integration and Cultural Context
1:47:35
Psychedelics in Historical Mythology (Vikings and Berserkers)
1:48:07
McKenna’s Stone Tape Theory Overview
1:48:38
Dennis’ Scientific Perspective on Psilocybin and Neuroplasticity
1:49:10
Evolutionary Hypothesis of Mushroom Use in Early Humans
1:50:13
Psychedelics as a Catalyst for Human Evolution
1:51:18
Space Perspective and Interconnectedness
1:52:20
Evil, Conflict, and the Need for New Thinking
1:52:50
Danger of Human Self and the Need for Study
1:53:20
Shadow Psychology and Projection onto Others
1:53:50
First DMT Experience with Terrence McKenna
1:54:23
Describing the Visual Journey of DMT
1:54:54
Realization of Universal Connection and Its Dark Implications
1:55:26
Linking Psychedelic Insight to Historical Trauma and MAPS Strategy
1:56:28
Ketamine Experience with Hitler Imagery and Grounding Techniques
1:57:30
Mass Mental Health Vision for MAPS
1:58:33
Drug Policy Reform and Education Initiatives
1:59:33
Historical Context of Nazi Drug Use and Its Consequences
2:00:35
War Tactics and Alcohol Consumption
2:01:05
Discussion of Berserkers and Mushroom Use
2:01:39
Genetic and Soil Influences on Psychoactive Plants
2:02:10
Amanita Mascaria and Viking Hallucinogens
2:02:43
Modern Research on Amanita and Other Psychedelics
2:04:16
Henbane and Historical Witchcraft Connections
2:04:46
Sacred Mushroom in Early Christianity
2:05:49
Genetic Studies of Amanita Persistence
2:06:19
Urgot and Ancient Psychedelic Traces
2:06:51
Suppression of Psychedelics in Ancient Societies
2:07:53
Multi-Generational Spiritual Projects
2:08:23
Personal Reflections on Health and Hope
2:08:55
Conference Promotion and Speaker Lineup
2:09:26
Event Structure and Music Integration
2:09:58
Cross-Training for Psychedelic Therapists
2:10:29
Conference Dates, Venue, and Attendance Highlights
2:11:00
Engaging Federal Agencies and Police Training
2:11:31
Global Expansion into Low-Resource Trauma Settings
2:12:02
Future FDA Approvals and Global Access Plans
2:12:35
Immigration History and Cultural Integration
2:13:06
Border Security, Citizenship Pathways, and Community Support
2:13:37
Final Thank Yous and Farewell
2h 58m⏭ 2
2h 21m⏭ 3
2h 53m⏭ 2
3h 1m⏭ 2
2h 54m⏭ 2
3h 35m
3h 7m⏭ 2
2h 39m⏭ 2
2h 58m⏭ 2
2h 34m⏭ 3
2h 19m
2h 49m⏭ 2
48m⏭ 1
1h 16m⏭ 4
1h 22m
1h 50m⏭ 3
1h 0m⏭ 1
31m⏭ 1
2h 15m⏭ 2
1h 1m
4h 6m⏭ 2
1h 28m⏭ 2
1h 42m⏭ 3
1h 0m⏭ 2